;
RCT
Published: Mar 2018
ACE Report #10151
Ace Report Cover Osteoarthritis

AAOS2018: TissueGene-C demonstrates 52-week efficacy versus placebo in treatment of moderate knee OA


Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A

TissueGene-C (TG-C), a Novel Cell and Gene Therapy for the Treatment of Osteoarthritis

Contributing Authors: MC Lee JH Lee CH Choi Y In J Yoo S Bin SD Cho CW Ha HS Kyung MG Kim E Choi HJ Ku

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CONFERENCE ACE REPORTS

This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.